Biond Biologics logo

Biond Biologics

Biond Biologics is an Israel-based immunotherapy company developing treatments for cancer and autoimmune diseases.

2

Funding Rounds

$32.0m

Money raised

Overview

Biond Biologics is an Israel-based immunotherapy company developing treatments for cancer and autoimmune diseases.

Funding

Funding series

Funding Series Analysis

The company Biond Biologics has raised a total of $32m in funding over 2 rounds.

Key Insights:

  • Biond Biologics Series C round, November 3, 2021: $15m
  • Biond Biologics Series B round, January 2019: $17m
Biond Biologics logo
Biond Biologics Series C round, November 3, 2021 $15m
Biond Biologics logo
Biond Biologics Series B round, January 2019 $17m